
Teva provides aggressive guidance for new drugs
Teva Pharmaceutical Industries Ltd. (NYSE AND TASE: TEVA) Makes an “Innovation and Day of Pray”, where it is mentioned the future of biopharmautical activity. The company sees income from three leading medicines: AUSDEDO, for treating unintentional moves; The control of migraine ajovy movement; and long-term movement of schizophrenia Uzedy, reaching at least $ 5…